Journal
MOLECULAR AND CLINICAL ONCOLOGY
Volume 5, Issue 1, Pages 132-134Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mco.2016.898
Keywords
prostate; sarcoma; leiomyosarcoma; immunohistochemistry; prognosis
Categories
Funding
- Key Project of Science and Technology of Zigong [2015SF03]
- Scientific research project of Health Department of Sichuan Province [110590]
Ask authors/readers for more resources
Prostate sarcoma, particularly the pathological type of leiomyosarcoma, is a rare carcinoma, which originated from the interstitial tissue of the prostate. This sarcoma type has a poor prognosis. This disease accounts for similar to 0.1% of all prostate cancer and it usually occurrs in patients aged between 40 and 78-years-old. Although prostate leiomyosarcoma has a poor prognosis, early treatment of post-operative recurrence and metastases via a whole-body examination and closer follow-up was possible. These measurements may significantly prolong the survival time and improve the quality of life. The present study reported a successful case of surgical management for prostate leiomyosarcoma in the Zigong No. 4 People's Hospital (Sichuan, China) during 1995 until 2015, with post-operative follow-up for 20 years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available